🕒 Saturday 3 October 2026 Sat, 3 Oct 2026

Small-cap shares delivered the week’s biggest moves, led by Mamba’s exploration funding and Cettire’s rebound. Clinical failures, cash shortages and delayed projects kept the broader market cautious.

DGR Global led the week after a Takeovers Panel finding raised fresh questions about control and voting rights. Smaller companies also exposed fragile finances, while several funds remained suspended or faced large investment losses.

Small-cap materials shares produced wide gains and losses as fresh discoveries competed with funding warnings and delayed mine starts.
Rare earths, lithium, gold and copper projects added scale, but approvals, cash and construction remain the key tests.

Clinical setbacks and cash shortages weighed on healthcare shares, while selected companies advanced on sales, regulatory and patent news.
Investors now face a simple test: which businesses can turn their latest announcements into funded operations and revenue?

Defence, artificial intelligence and government contracts drove the week’s biggest technology share moves, while several smaller companies warned they may need more cash.
Micro-X, RMA Global and Stakk led the price rises, but refinancing pressure remained a major concern across the sector.